Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Debt / NOTE 1.000%11/1
-
Market price (% of par)
-
101.51%
-
Total 13F principal
-
$291,876,400
-
Principal change
-
+$80,066,000
-
Total reported market value
-
$299,156,298
-
Number of holders
-
41
-
Value change
-
+$81,055,775
-
Number of buys
-
16
-
Number of sells
-
15
Institutional Holders of ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 as of Q1 2021
As of 31 Mar 2021,
ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 was held by
41 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$291,876,400
in principal (par value) of the bond.
The largest 10 bondholders included
TENOR CAPITAL MANAGEMENT Co., L.P., D. E. Shaw & Co., Inc., MACKAY SHIELDS LLC, Farallon Capital Management, L.L.C., III Capital Management, STATE STREET CORP, Polygon Management Ltd., PALISADE CAPITAL MANAGEMENT LLC/NJ, BNP PARIBAS ASSET MANAGEMENT Holding S.A., and RWC Asset Management LLP.
This page lists
41
institutional bondholders reporting positions
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.